Highlights
A new family of indole-containing arene ruthenium organometallic compounds are active against several bacterial species and drug resistant strains
Bactericidal activity observed against various Gram negative, Gram positive and acid-fast bacteria, demonstrating broad-spectrum inhibitory activity
Compound series exhibits low toxicity against human cells
Shows considerable promise as next generation antibiotics
The synthesis, characterisation and evaluation of the in vitro cytotoxicity of four indole-based half-sandwich metal complexes towards two ovarian cancer cell lines (A2780 and A2780cisR) and one normal prostate cell line (PNT2) are presented herein. Although capable of inducing catalytic oxidation of NADH and able to reduce NAD+ with high turnover frequencies, in cells and in the presence of sodium formate, these complexes also strongly interact with biomolecules such as glutathione. This work highlights that efficient out-of-cells catalytic activity might lead to higher reactivity towards biomolecules, thus inhibiting the in-cells catalytic processes.
The
precursor PPyrCl
2
(Pyr
= 1-pyrenyl) has been used to prepare a number of novel 1-pyrenylphosphines.
Treatment of PPyrCl
2
with methylmagnesium
chloride has provided the phosphine PPyrMe2, with methanol/triethylamine,
the phosphonite PPyr(OMe)2 (1), with dimethylamine/triethylamine,
the diaminophosphine PPyr(NMe2)2 (2), and with lithium aluminum hydride, PPyrH2 (3). From this primary phosphine, phosphirane PPyr(CH2CH2) (5) has been obtained. The phosphine PPyr2Ph (6) has been synthesized from 1-bromopyrene,
while 1-bromo-2-(1-pyrenyl)benzene has been used to prepare Ph-PyrPhos
(7) and i-Pr-PyrPhos (8). The new phosphines have subsequently been used to obtain the corresponding
[RuCl2(η6-arene)(PPyrR2)] complexes C1
Cym
–C3
Cym
and C6
Cym
–C8
Cym
(arene = p-cymene;
Cym) and C1
Mba
–C3
Mba
and C6
Mba
–C8
Mba
(arene =
methyl benzoate; Mba), which have been fully characterized; the crystal
structures of C1
Cym
, C1
Mba
, C2
Cym
, C2
Mba
, C6
Mba
, and C7
Cym
were determined by X-ray diffraction. Substitution of the
methyl benzoate fragment of complexes C7
Mba
and C8
Mba
by the η6-coordinated pyrenyl group of the coordinated phosphine was
achieved photochemically, giving the tethered complexes C7
Tet
and C8
Tet
. In these two complexes the phosphine acts as a κ1,η6-coordinated ligand, as evidenced by the
X-ray structure of C8
Tet
. The
antineoplastic activities of the piano-stool Ru compounds revealed
that they are highly phosphine dependent and two compounds, namely C1
Cym
and C2
Cym
, exhibit interesting biological properties.
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.